Table 1 Characteristics of patients in this study

From: The dichotomous and incomplete adaptive immunity in COVID-19 patients with different disease severity

 

All

(n = 72)

Healthy (n = 8)

Asymptomatic

(n = 10)

Mild

(n = 10)

Moderate

(n = 32)

Severe

(n = 12)

Age (years, median, IOQ)

67 (19–74)

30.5 (25–38)

21 (19–56)

30 (19–56)

39.5 (20–67)

65 (43–74)

Gender

      

 Female

37

4

4

6

17

6

 Male

35

4

6

4

15

6

Onset of discharge to sample collection (days, median, IOQ)

14 (10–17)

 

13.5 (10–15)

13.5 (10–14)

13.5 (10–16)

14 (14–17)

Duration of hospitalization

19 (7–51)

 

24 (12–51)

22 (12–31)

16.5 (7–29)

26 (13–34)

Hospital admission date (medium IQR)

2020/2/18

(2020/2/06

to

2020/4/24)

 

2020/3/28

(2020/3/22

to

2020/4/15)

2020/4/09

(2020/2/08

to 2020/4/24)

2020/2/13

(2020/2/02

to

2020/3/06)

2020/2/21

(2020/2/06

to

2020/3/12)

  1. 1. Continuous variables were shown as the median (interquartile range, IQR)
  2. 2. All of 64 COVID-19 patients were tested positive qPCR for SARS-CoV-2 virus RNA upon hospital admission. Patients were diagnosed as severe when meeting any one of the following conditions: (1) anhelation (RR ≥ 30/min), (2) SpO2 ≤ 93%, (3) PaO2/FiO2 ≤ 300 mmHg and (4) imageological diagnosis of significant progress (> 0%) in 24–48 h. The moderate patients were diagnosed with respiratory symptoms, fever and imageological evidence of pneumonia
  3. The mild patients were diagnosed with mild clinical symptoms and no imageological evidence of pneumonia. The asymptomatic patients were those without any clinical symptoms